Evidence map›Paper›PMID 41954363›Full record

ReviewPathologica2026

Standardisation of histologic reporting in eosinophilic oesophagitis: Expert recommendations.

Carla Giordano, Valentina Angerilli, Marco Masci, Maria D'Armiento, Paola Parente, Emanuela Pilozzi, Alessandro Vanoli, Salvatore Oliva, Edoardo Vincenzo Savarino, Matteo Fassan and 1 more

Abstract readConsensus StatementReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carla GiordanoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Valentina Angerilli *Surgical Pathology Unit, ULSS2 Marca Trevigiana, Treviso, Italy.
Marco Masci *Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Maria D'ArmientoDepartment of Public Health, School of Medicine, University "Federico II", Naples, Italy.
Paola ParenteUnit of Pathology, IRCCS Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, Italy.
Emanuela PilozziDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Alessandro VanoliDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Salvatore OlivaPediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza University of Rome, Rome, Italy.
Edoardo Vincenzo SavarinoDepartment of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Matteo FassanDepartment of Medicine (DIMED), University of Padua, Padua, Italy.
Luca Mastracci *Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, significant progress has been made in understanding eosinophilic oesophagitis (EoE), leading to the refinement of diagnostic criteria and the development of evidence-based management guidelines. Nevertheless, despite the central role of histology in both diagnosis and disease monitoring, significant variability remains in histopathological reporting across institutions and among pathologists.This study seeks to provide recommendations for standardised histological reporting in EoE. To this end, a multidisciplinary panel of gastroenterologists and pathologists convened to review current practices and address persistent challenges in histologic assessment. Through an extensive literature review and critical appraisal of existing scoring systems, the panel reached consensus on both essential and desirable histological features for routine reporting, including eosinophil counts, additional inflammatory parameters, and fibrostenotic changes.

Indexed as

Eosinophilic EsophagitisEsophagusEosinophilsHumansdiagnosisEosinophilic oesophagitisfollow-uphistopathologystandardisation

Identifiers

PMID41954363
PMCPMC13094330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.